Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Clevidipine for acute hypertension in intracerebral hemorrhage
2008-000230-53Phase 3Completed
- Sponsor
- The Medicines Company
- Start
- Mar 2008
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3, open-label, single-arm trial of clevidipine in intracerebral hemorrhage (ICH) and hypertensive crisis, sponsored by The Medicines Company. Primary endpoint: Median time to achieve target systolic blood pressure. Started Mar 2008; status: completed.
02
Drugs
clevidipine
03
Conditions
intracerebral hemorrhage (ICH)hypertensive crisis
Beyond the preview
Go deeper on 2008-000230-53.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2008-000230-53.